Health and Fitness Health and Fitness
Wed, January 7, 2009
[ Wed, Jan 07th 2009 ] - Market Wire
Siteman Cancer Center Adds Second TomoTherapy® HiArt® Treatment System
[ Wed, Jan 07th 2009 ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Acusphere, Inc. Announces Resignation of Richard Walovitch
[ Wed, Jan 07th 2009 ] - Market Wire
Alkermes? Corporate Presentation to be Webcast at JPMorgan Annual Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Alnylam to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Transcend Announces Completion of Acquisition of DeVenture Health Partners
[ Wed, Jan 07th 2009 ] - Market Wire
Adolor Corporation Announces Management Appointments
[ Wed, Jan 07th 2009 ] - Market Wire
RehabCare to Present at the 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Clinical Data, Inc. Reports Advances in Two Late-Stage Therapeutic Programs
[ Wed, Jan 07th 2009 ] - Market Wire
Amedisys to Present at the 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Skilled Healthcare to Present at the 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Lifeline Biotechnologies, Inc. Will Focus on Marketing Its First Warning System" in 2009
[ Wed, Jan 07th 2009 ] - Market Wire
LifePoint Hospitals to Participate in 27th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Bio-Imaging Technologies Sells CapMed Division to Metavante Technologies
[ Wed, Jan 07th 2009 ] - Market Wire
Pacific Biometrics, Inc.: Pacific Biometrics, Inc .. ding Laurus Master Fund and Franklin Funding Debt
[ Wed, Jan 07th 2009 ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies CEO .. 's Diagnostics Development Strategy With CEORoads
[ Wed, Jan 07th 2009 ] - Market Wire
Genzyme to Present at 27th Annual JPMorgan Healthcare Conference
[ Wed, Jan 07th 2009 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Approved for Healthcare National Provider Registry
[ Wed, Jan 07th 2009 ] - Market Wire
Marshall Edwards, Inc.: Marshall Edwards, Inc. Granted IND for Triphendiol
[ Wed, Jan 07th 2009 ] - Market Wire
ACADIA Pharmaceuticals Awarded Grant from The Mic .. e Development of Novel ER-beta Agonists for the T
[ Wed, Jan 07th 2009 ] - Market Wire
Synergetics USA, Inc. Announces 3 Month Extension .. Codman & Shurtleff, Inc. as Longer Term Agreement
[ Wed, Jan 07th 2009 ] - Market Wire
OR-Live, Inc.: REMINDER: Cardica Announces Webcas .. Cardiothoracic Surgeon, Dr. Sudhir Srivastava, P
[ Wed, Jan 07th 2009 ] - Market Wire
Synta and Roche Form Discovery, Development, and Commercialization Alliance in Inflammation
[ Wed, Jan 07th 2009 ] - Market Wire
Columbia Laboratories Raises $750,000 through Sale of Common Stock
Tue, January 6, 2009
[ Tue, Jan 06th 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC announces European Product Approval
[ Tue, Jan 06th 2009 ] - Market Wire
Emergent BioSolutions Ends Efforts to Acquire Protein Sciences
[ Tue, Jan 06th 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar/TMI Announ .. tion of HIPAA Compliance Guideline and Procedures
[ Tue, Jan 06th 2009 ] - Market Wire
Robert Bosch North America: Robert Bosch North Am .. ailability of Single License for Joint Patent Por
[ Tue, Jan 06th 2009 ] - Market Wire
The Medicines Company: The Medicines Company to P .. n the 27th Annual JP Morgan Healthcare Conference

The Medicines Company: The Medicines Company to Participate in the 27th Annual JP Morgan Healthcare Conference


Published on 2009-01-06 14:45:50, Last Modified on 2009-01-06 14:46:11 - Market Wire
  Print publication without navigation


PARSIPPANY, NJ--(Marketwire - January 6, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) is scheduled to participate in the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A company overview and outlook will be provided in the presentation.

The session will be webcast with a link available at The Medicines Company's website: [ http://www.themedicinescompany.com ].

MDCO-G

About The Medicines Company

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU-2010, in early-stage development. The Company's website is [ www.themedicinescompany.com ].

Contributing Sources